Laman Alani
34Patents
7h-index
50Co-inventors
72Inventor score
Filing activity: Dec 8, 1998 → Aug 22, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8377474B2 | Controlled release formulations of levodopa and uses thereof | Chemistry; Metallurgy | 39 | Active |
| US8791154B2 | High concentration olopatadine ophthalmic composition | Chemistry; Metallurgy | 27 | Active |
| US10689438B2 | Stable protein solution formulation containing high concentration of an anti-VEGF antibody | Chemistry; Metallurgy | 10 | Active |
| US8025899B2 | Solid pharmaceutical dosage form | Human Necessities | 10 | Active |
| US8268349B2 | Solid pharmaceutical dosage form | Human Necessities | 9 | Active |
| US8486983B2 | Self-emulsifying formulations of CETP inhibitors | Human Necessities | 7 | Active |
| US8557283B2 | Controlled release formulations of levodopa and uses thereof | Chemistry; Metallurgy | 7 | Active |
| US6284767A | Retroviral protease inhibiting compounds | Chemistry; Metallurgy | 7 | Expired |
| US9089608B2 | Controlled release formulations of levodopa and uses thereof | Chemistry; Metallurgy | 5 | Active |
| US9089607B2 | Controlled release formulations of levodopa and uses thereof | Chemistry; Metallurgy | 5 | Active |
| US7141593B1 | Pharmaceutical formulations | Human Necessities | 4 | Expired |
| US7432294B2 | Pharmaceutical formulations | Human Necessities | 4 | Active |
| US9463246B2 | Controlled release formulations of levodopa and uses thereof | Chemistry; Metallurgy | 3 | Active |
| US6911214B2 | Flavoring systems for pharmaceutical compositions and methods of making such compositions | Human Necessities | 3 | Expired |
| US8377952B2 | Solid pharmaceutical dosage formulation | Human Necessities | 3 | Active |
| US8454998B2 | Controlled release formulations of levodopa and uses thereof | Chemistry; Metallurgy | 3 | Active |
| US8691878B2 | Solid pharmaceutical dosage form | Human Necessities | 2 | Active |
| US8399015B2 | Solid pharmaceutical dosage form | Human Necessities | 2 | Active |
| US7981911B2 | Pharmaceutical formulations | Human Necessities | 1 | Active |
| US11419822B2 | High concentration formulations of anti-CSF1 and anti-CSF1R antibodies | Chemistry; Metallurgy | 1 | Active |
| US8501219B2 | Flavoring systems for pharmaceutical compositions and methods of making such compositions | Human Necessities | 1 | Active |
| US8333990B2 | Solid pharmaceutical dosage form | Human Necessities | 1 | Active |
| US8414921B2 | Pharmaceutical compositions of combinations of dipeptidyl peptidase-4 inhibitors with metformin | Human Necessities | 1 | Active |
| US12049495B2 | Stable protein solution formulation containing high concentration of an anti-VEGF antibody | Chemistry; Metallurgy | 0 | Active |
| US8895051B2 | Flavoring systems for pharmaceutical compositions and methods of making such compositions | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.